The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats

被引:47
作者
Wenger, T
Gerendai, I
Fezza, F
González, S
Bisogno, T
Fernandez-Ruiz, J
Di Marzo, V
机构
[1] Semmelweis Univ, Dept Human Morphol & Dev Biol, H-1450 Budapest, Hungary
[2] CNR, Ist Chim Mol Interesse Biol, Endocannabinoid Res Grp, I-80072 Arco Felice Napoli, Napoli, Italy
[3] Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain
基金
新加坡国家研究基金会;
关键词
cannabinoid; hypothalamus; puberty; rat;
D O I
10.1016/S0024-3205(01)01516-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Several data suggest that the endogenous cannabinoid system plays a role in neuroendocrine regulation in adult individuals, although the information on its involvement in peri-pubertal processes is scarce. In the present study, we have examined the ontogeny (from postnatal day [PND] 5 up to adulthood) of hypothalamic and anterior pituitary contents of anandamide (arachidonyl-ethanolamide, AEA). We observed that the content of AEA in the hypothalamus was low at PND5, PND15 and PND25, but it markedly increased (approximately 3-fold) immediately before the puberty (on the day of 1st proestrus), to return to intermediate values immediately after the vaginal opening (day of 2nd proestrus) and, eventually, adulthood. By contrast, no consistent differences were observed in AEA levels in the anterior pituitary. These results demonstrate the occurrence of a parallelism between the peri-pubertal events and a rise in the hypothalamic content of AEA immediately before the puberty, which might indicate that this endocannabinoid may be involved in the onset of puberty in rats. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1407 / 1414
页数:8
相关论文
共 28 条
[1]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[2]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[3]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[4]   Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice:: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain [J].
Di Marzo, V ;
Breivogel, CS ;
Tao, Q ;
Bridgen, DT ;
Razdan, RK ;
Zimmer, AM ;
Zimmer, A ;
Martin, BR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2434-2444
[5]  
DIMARZO V, 1997, INTERNET J SCI BIOL, V1, P1
[6]   Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat [J].
Felder, CC ;
Nielsen, A ;
Briley, EM ;
Palkovits, M ;
Priller, J ;
Axelrod, J ;
Nguyen, DN ;
Richardson, JM ;
Riggin, RM ;
Koppel, GA ;
Paul, SM ;
Becker, GW .
FEBS LETTERS, 1996, 393 (2-3) :231-235
[7]   Cannabinoid receptors and their endogenous agonists [J].
Felder, CC ;
Glass, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 :179-200
[8]  
FELDER CC, 1992, MOL PHARMACOL, V42, P838
[9]   The endogenous cannabinoid system and brain development [J].
Fernández-Ruiz, J ;
Berrendero, F ;
Hernáandez, ML ;
Ramos, JA .
TRENDS IN NEUROSCIENCES, 2000, 23 (01) :14-20
[10]   ANALYSIS OF ANANDAMIDE, AN ENDOGENOUS CANNABINOID SUBSTANCE, AND OF OTHER NATURAL N-ACYLETHANOLAMINES [J].
FONTANA, A ;
DIMARZO, V ;
CADAS, H ;
PIOMELLI, D .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 53 (04) :301-308